Standout Papers
- Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase (1998)
- Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia (1998)
- Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances Angiogenesis (2003)
- Ischemic Brain Injury is Mediated by the Activation of Poly(ADP-Ribose)Polymerase (1997)
- The Post-COVID-19 Functional Status scale: a tool to measure functional status over time after COVID-19 (2020)
Immediate Impact
5 by Nobel laureates 12 from Science/Nature 77 standout
Citing Papers
Pharmacology and Clinical Development of Factor XI Inhibitors
2023 Standout
The immunology and immunopathology of COVID-19
2022 StandoutScience
Works of Matthias Endres being referenced
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention
2022
High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Matthias Endres | 5364 | 3537 | 6677 | 3917 | 546 | 23.3k | |
| Zoltán Ungvári | 2538 | 3841 | 6890 | 3876 | 409 | 23.9k | |
| Ulrich Dirnagl | 4810 | 2329 | 8760 | 9308 | 378 | 34.3k | |
| Marc Fisher | 8056 | 3503 | 2845 | 4149 | 332 | 19.9k | |
| Louise D. McCullough | 3565 | 1454 | 5490 | 5741 | 373 | 19.8k | |
| Mei Lü | 5644 | 726 | 6899 | 4623 | 366 | 23.7k | |
| Chung Y. Hsu | 3032 | 959 | 5726 | 3098 | 460 | 19.4k | |
| Martin Dichgans | 5724 | 2651 | 4772 | 6175 | 416 | 27.2k | |
| Peter P. Nawroth | 3957 | 2680 | 9619 | 2648 | 487 | 35.7k | |
| Donald D. Heistad | 2164 | 9031 | 5021 | 2264 | 458 | 25.1k | |
| Anna Csiszár | 2258 | 3089 | 5983 | 3624 | 309 | 20.9k |
All Works
Login with ORCID to disown or claim papers
Loading papers...